MSON Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally...

Stats
Today's Volume	157 169
Average Volume	57 194.00
Market Cap	0.00
EPS	$-0.260 ( 2021-09-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.641 (2.42%)

Insider Trading

Date	Person	Action	Amount	type
2021-10-29	Vizirgianakis Stavros G.	Sell	2 136 478	Common Stock
2021-10-29	Patton Thomas M	Sell	104 500	Common Stock
2021-10-29	Laviolette Paul A	Sell	1 744 017	Common Stock
2021-10-29	Dwyer Joseph P	Sell	276 200	Common Stock
2021-06-30	Waggoner Jonathan Jay	Buy	15 000	Stock Option

INSIDER POWER
0.00
Last 98 transactions
Buy: 1 378 801 \| Sell: 4 339 021

Volume Correlation

Long: 0.25 (neutral)

Short: 0.60 (weak)

Signal:(63.159) Neutral

Misonix Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Misonix Inc Correlation - Currency/Commodity

0.72
( moderate )

0.76
( moderate )

0.72
( moderate )

-0.31
( neutral )

0.75
( moderate )

-0.65
( moderate negative )

Misonix Inc Financials

Annual	2021
Revenue:	$74.02M
Gross Profit:	$52.64M (71.11 %)
EPS:	$-0.987

Q4	2021
Revenue:	$19.69M
Gross Profit:	$14.08M (71.50 %)
EPS:	$-0.260

Q3	2021
Revenue:	$18.35M
Gross Profit:	$12.94M (70.55 %)
EPS:	$-0.220

Q2	2021
Revenue:	$18.26M
Gross Profit:	$12.99M (71.16 %)
EPS:	$-0.0700

Financial Reports:

No articles found.

Misonix Inc

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.